Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric F Morand

Showing results (41-50 of 226) with videos related to

Pageof 23
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 21, 2019
Assays for Inducing and Measuring Cell Death to Detect Macrophage Migration Inhibitory Factor (MIF) ReleaseShahrzad Zamani, Eric F Morand, Jacqueline K Flynn
Immunology and Cell Biology|September 13, 2003
Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus?Alberta Y Hoi, Eric F Morand, Michelle Leech
Nature Reviews. Rheumatology|July 23, 2014
The need to define treatment goals for systemic lupus erythematosusKate Franklyn, Alberta Hoi, Mandana Nikpour, et al.
Inflammation & Allergy Drug Targets|September 28, 2007
Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseasesAlberta Y Hoi, Magdy N Iskander, Eric F Morand
Lupus Science & Medicine|May 21, 2026
Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial dataAngela Lin, Rangi Kandane-Rathnayake, Eric F Morand, et al.
Infection, Disease & Health|December 7, 2020
Breaking the chain of transmission within a tertiary health service: An approach to contact tracing during the COVID-19 pandemicRhonda L Stuart, Wendy Zhu, Eric F Morand, et al.
Mediators of Inflammation|August 3, 2006
Regulation of annexin I in rheumatoid synovial cells by glucocorticoids and interleukin-1Eric F Morand, Pam Hall, Paul Hutchinson, et al.
Nature Reviews. Rheumatology|March 12, 2014
The BAFF/APRIL system in SLE pathogenesisFabien B Vincent, Eric F Morand, Pascal Schneider, et al.
The Lancet. Rheumatology|January 30, 2024
Clinician-reported outcome measures in lupus trials: a problem worth solvingKathryn Connelly, Vera Golder, Rangi Kandane-Rathnayake, et al.
Journal of Inflammation (London, England)|August 26, 2009
Modulation of expression and cellular distribution of p21 by macrophage migration inhibitory factorElliott Taranto, Jin R Xue, Eric F Morand, et al.
Pageof 23

Showing results (41-50 of 226) with videos related to

Sort By:
Pageof 23
Methods in Molecular Biology (Clifton, N.J.)|November 21, 2019
Assays for Inducing and Measuring Cell Death to Detect Macrophage Migration Inhibitory Factor (MIF) ReleaseShahrzad Zamani, Eric F Morand, Jacqueline K Flynn
Immunology and Cell Biology|September 13, 2003
Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus?Alberta Y Hoi, Eric F Morand, Michelle Leech
Nature Reviews. Rheumatology|July 23, 2014
The need to define treatment goals for systemic lupus erythematosusKate Franklyn, Alberta Hoi, Mandana Nikpour, et al.
Inflammation & Allergy Drug Targets|September 28, 2007
Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseasesAlberta Y Hoi, Magdy N Iskander, Eric F Morand
Lupus Science & Medicine|May 21, 2026
Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial dataAngela Lin, Rangi Kandane-Rathnayake, Eric F Morand, et al.
Infection, Disease & Health|December 7, 2020
Breaking the chain of transmission within a tertiary health service: An approach to contact tracing during the COVID-19 pandemicRhonda L Stuart, Wendy Zhu, Eric F Morand, et al.
Mediators of Inflammation|August 3, 2006
Regulation of annexin I in rheumatoid synovial cells by glucocorticoids and interleukin-1Eric F Morand, Pam Hall, Paul Hutchinson, et al.
Nature Reviews. Rheumatology|March 12, 2014
The BAFF/APRIL system in SLE pathogenesisFabien B Vincent, Eric F Morand, Pascal Schneider, et al.
The Lancet. Rheumatology|January 30, 2024
Clinician-reported outcome measures in lupus trials: a problem worth solvingKathryn Connelly, Vera Golder, Rangi Kandane-Rathnayake, et al.
Journal of Inflammation (London, England)|August 26, 2009
Modulation of expression and cellular distribution of p21 by macrophage migration inhibitory factorElliott Taranto, Jin R Xue, Eric F Morand, et al.
Pageof 23